Skip to Content
Get key facts and figures about chronic dry eye

Eylea (aflibercept ophthalmic) Drug Interactions

There are no known drug interactions for Eylea (aflibercept ophthalmic) - however, this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.

Eylea (aflibercept ophthalmic) is in the drug class anti-angiogenic ophthalmic agents. Eylea (aflibercept ophthalmic) is used to treat the following conditions: Diabetic Macular Edema, Diabetic Retinopathy, Macular Degeneration, Macular Edema.

Eylea (aflibercept ophthalmic) disease interactions

There is 1 disease interaction with Eylea (aflibercept ophthalmic):

Drug Interaction Classification

The classifications below are a general guideline only. It is difficult to determine the relevance of a particular drug interaction to any individual given the large number of variables.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No information available.

Do not stop taking any medications without consulting your healthcare provider.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.